Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 2:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1681–1704 of 1,742 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Study Device Arm Clear all

Conditions: Incomplete Spinal Cord Injury, Muscular Dystrophy, Spina Bifida, Cerebral Palsy
Interventions: EA-KAFO; Device
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 5 Years to 100 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: COPD
Interventions: Lung Flute; Device
Lead sponsor: Nicolaas J Smit PhD; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Aortic Aneurysm, Thoracic
Interventions: GORE® TAG® Thoracic Branch Endoprosthesis; Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2022
U.S. locations: 6
States / cities: Stanford, California • Ann Arbor, Michigan • Rochester, Minnesota + 3 more

Conditions: Traumatic Brain Injury, TBI, Sleep
Interventions: Bright White Light (BWL), Red Light (RL); Device
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 70 Years
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
Interventions: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Cytarabine, Daunorubicin, Echocardiography Test, Fludarabine, Idarubicin, Multigated Acquisition Scan, Questionnaire Administration, Venetoclax, Device FLT3 Inhibitor; Procedure · Drug · Other + 1 more
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Kidney Transplant, Liver Transplant
Interventions: MoveMend Health; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Colon Adenoma, Colon Polyp, Colon Lesion
Interventions: Computer-Assisted Detection (CADe) Device; Device
Lead sponsor: Verily Life Sciences LLC; Industry
Eligibility: 45 Years to 80 Years
Enrollment: 1,410 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 5
States / cities: Rochester, Minnesota • Durham, North Carolina • Mentor, Ohio + 2 more

Conditions: Posttraumatic Stress Disorder
Interventions: Neuropeptide Y; Drug
Lead sponsor: James Murrough; Other
Eligibility: 18 Years to 60 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Neurological Disorder, ALS (Amyotrophic Lateral Sclerosis), Motor Neuron Disease, ALS - Amyotrophic Lateral Sclerosis, ALS
Interventions: Stentrode; Device
Lead sponsor: Synchron, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 5
States / cities: Jacksonville, Florida • Buffalo, New York • New York, New York + 2 more

Conditions: Tooth Extraction, Immediate Implant Placement
Interventions: Xenogeneic Volume-Stable Collagen (VCMX) graft with growth factor-BB; Device
Lead sponsor: I-Ching Wang; Other
Eligibility: 18 Years to 95 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Pain
Interventions: Ethyl Chloride Topical Aerosol Anesthetic, Nature's Tears Sterile Water; Drug
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: Bionic Pancreas, Usual Care; Device · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Rheumatoid Arthritis
Interventions: Vorso PROTECT System, Vorso PROTECT System - Sham (OFF); Device
Lead sponsor: Nesos Corp; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Duncansville, Pennsylvania

Conditions: Tricuspid Valve Regurgitation, Tricuspid Valve Disease, Cardiovascular Diseases (CVD), Heart Valve Diseases, Tricuspid Valve Insufficiency, Severe Heart Valve Disease, Randomized Controlled Trial (RCT), Symptomatic Tricuspid Regurgitation
Interventions: Transcatheter Tricuspid Valve Replacement (TTVR) with VDyne TriNova System, Transcatheter Tricuspid Valve Replacement (TTVR) with Edwards EVOQUE System; Device
Lead sponsor: VDyne, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 520 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2036
U.S. locations: 12
States / cities: Phoenix, Arizona • Scottsdale, Arizona • San Francisco, California + 8 more

Conditions: Gastric Procedures, Lung Resection Procedures
Interventions: Staple Line Reinforcement; Device
Lead sponsor: Ethicon Endo-Surgery; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 8
States / cities: Indianapolis, Indiana • Baton Rouge, Louisiana • Detroit, Michigan + 5 more

Conditions: Surgical Wound Healing, Lower Extremity, Revascularization, Incision
Interventions: EPIFLO; Device
Lead sponsor: Neogenix, LLC dba Ogenix; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Multiple Myeloma, Refractory Multiple Myeloma
Interventions: Digital Health Coaching Program, Fitbit; Behavioral · Device
Lead sponsor: Pack Health; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Houston, Texas • Seattle, Washington

Conditions: Type 2 Diabetes
Interventions: The DECIDE Self-Management Program, Continuous Glucose Monitoring (CGM); Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis
Interventions: Closed Loop Trans-Auricular Vagus Nerve Stimulation System, Placebo; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 70 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Reperfusion Injury, Post Cardiac Arrest Brain Injury
Interventions: LUTICIA - Light Utilization COX-Inhibitory Device); Device
Lead sponsor: Mitovation, Inc; Industry
Eligibility: 48 Hours to 1 Year
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Bacterial Vaginosis
Interventions: Flourish HEC Vaginal Care System; Device
Lead sponsor: Vaginal Biome Science; Other
Eligibility: 18 Years to 52 Years · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Diabetes
Interventions: Home Telehealth with Behavioral Education Component; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Impaired Wound Healing, Venous Insufficiency of Leg, Diabetic Ulcers
Lead sponsor: SerenaGroup, Inc.; Network
Eligibility: 18 Years and older
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 18
States / cities: Boca Raton, Florida • Homestead, Florida • Largo, Florida + 15 more

Conditions: Migraine
Interventions: Nerivio; Device
Lead sponsor: Theranica; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 293 participants
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Search by objective public record fields.

Evaluating a New Knee-Ankle-Foot Brace to Improve Gait in Children With Movement Disorders

A Six Month Randomized Controlled Clinical Trial of Lung Flute in Patients With Chronic Obstructive Pulmonary Disease

Feasibility Study for GORE® TAG® Thoracic Branch Endoprosthesis to Treat Proximal Descending Thoracic Aortic Aneurysms

TWILIGHT Study: Effect of Light Exposure During Acute Rehabilitation on Sleep After TBI

Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia

Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized Patients

Gastroenterology Artificial INtelligence System for Detecting Colorectal Polyps (The GAIN Study)

A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD)

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

Immediate Implant Placement Using Volume-Stable Collagen Matrix Combined With rhPDGF-BB

Skin Refrigerant to Reduce the Pain Associated With IV Insertion

The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance

The RA PROTECTION Study

VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)

Study of ECHELON ENDOPATH(TM) Staple Line Reinforcement

Oxygen for Vascular Incisional Healing

Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab

Feasibility of a Diabetes Self-Management Program With Continuous Glucose Monitoring for Adults With Type 2 Diabetes

Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional Recovery

Light Utilization COX-Inhibitory Device Therapy for Infant Cardiac Arrest (LUTICA Study). The LUCID Device is Used in the Treatment of Ischemic Brain Reperfusion Injury Caused by Cardiac Arrest in Pediatric Patients.

Effect of Flourish HEC Vaginal Care System on BV Recurrence and the Vaginal Microbiome

Advanced Comprehensive Diabetes Care for Veterans With Poorly-Controlled Diabetes

Clinical Trial to Evaluate Blister Graft Utilizing a Novel Harvesting Device for Treatment of Venous Leg Ulcers

Acute Treatment of Migraine in Pre-Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN)